Interferon-γ-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members

Blood

Volumn 96, Issue 13, 2000, Pages 4204-4211

  Rathbun, R Keaney ^b   Christianson, Tracy A ^b   Faulkner, Gregory R ^b   Jones, Gary ^b   Keeble, Winifred ^b   O'Dwyer, Michael ^b   Bagby, Grover C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, MOUSE; CASP8 PROTEIN, HUMAN; CASP8 PROTEIN, MOUSE; CASP9 PROTEIN, HUMAN; CASP9 PROTEIN, MOUSE; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CELL CYCLE PROTEIN; CYSTEINE PROTEINASE INHIBITOR; DNA BINDING PROTEIN; FANCC PROTEIN, HUMAN; FANCC PROTEIN, MOUSE; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA PROTEIN; FAS ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; ISOENZYME; NUCLEAR PROTEIN; PROTEIN; RECOMBINANT GAMMA INTERFERON;

ANIMAL; APOPTOSIS; ARTICLE; BONE MARROW; C57BL MOUSE; CELL CULTURE; CELL LINE; CHILD; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME SPECIFICITY; ENZYMOLOGY; FANCONI ANEMIA; GENETIC HETEROGENEITY; GENETIC TRANSFECTION; GENETICS; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BONE MARROW; CASPASE 1; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHILD; CYSTEINE PROTEINASE INHIBITORS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENETIC HETEROGENEITY; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; PROTEINS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 0034672372     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4204.h8004204_4204_4211     Document Type: Article

References (22)

1. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients: a review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet. 1991;51:1-12.
2. Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry Study. Blood. 1994;84:1650-1655.
3. Liu JM, Buchwald M, Walsh CE, Young NS. Fanconi anemia and novel strategies for therapy. Blood. 1994;84:3995-4007.
4. Schroeder TM, Tilgen D, Kruger J, Vogel F. Formal genetics of Fanconi's anemia. Hum Genet. 1976;32:257-288.
5. Auerbach AD, Adler B, Chaganti RS. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics. 1981;67:128-135.
6. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73:391-396.
7. Joenje H, Ten Foe JRL, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood. 1995;86:2156-2160.
8. Joenje H, Oostra AB, Wijker M, et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet. 1997;61:940-944.
9. Strathdee CA, Duncan AM, Buchwald M. Evi-dence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet. 1992;1:196-198.
10. Joenje H, Levitus M, Waisfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet. 2000;67:759-762.
11. Saar K, Schindler D, Wegner RD, et al. Localisation of a Fanconi anaemia gene to chromosome 9p. Eur J Hum Genet. 1998;6:501-508.
12. Gibson RA, Ford D, Jansen S, et al. Genetic mapping of the FACC gene and linkage analysis in Fanconi anaemia families. J Med Genet. 1994;31:868-871.
13. Whitney M, Thayer M, Reifsteck C, et al. Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet. 1995;11:341-343.
14. Pronk JC, Gibson RA, Savoia A, et al. Localization of the Fanconi anaemia complementation group A gene to chromosome 16q24.3. Nat Genet. 1995;11:338-340.
15. Wevrick R, Clarke CA, Buchwald M. Cloning and analysis of the murine Fanconi anemia group C cDNA. Hum Mol Genet. 1993;2:655-662.
16. Yamashita T, Barber DL, Zhu Y, Wu N, D'Andrea AD. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA. 1994;91:6712-6716.
17. Youssoufian H. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA. 1994;91:7975-7979.
18. Hoatlin ME, Christianson TA, Keeble WW, et al. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. Blood. 1998;91:1418-1425.
19. Kupfer GM, Näf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet. 1997;17:487-490.
20. Youssoufian H. Cytoplasmic localization of FAC is essential for the correction of a pre-repair defect in Fanconi anemia group C cells. J Clin Invest. 1996;97:2003-2010.
21. Segal GM, Magenis E, Brown M, et al. Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest. 1994;94:846-852.
22. Walsh CE, Grompe M, Vanin E, et al. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C. Blood. 1994;84:453-459.